Saturday, October 10, 2026

Hippo Holdings ($HIPO): The Insurtech That Stopped Chasing Hype and Started Making Money

Hippo’s insurance platform posted 61% premium growth, a 95.8% combined ratio and a fifth profitable quarter as it shifted toward carrier and MGA fee income.

HIPO $903M

Substack von Philipp 45h ago 5 clicks

Oct 9 GLNG $4.9B

You Understand Now, Why You Came This Way

WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Oct 9 SNPS $97B

Synopsys (NASDAQ: SNPS) Stock Rating: DISTRIBUTE Ahead Of Q4 FY10/26 Earnings

Cestrian Capital Research 3 clicks

From X

@stockgutter Oct 8

SG on X

let me be the curmudgeon and point out that these announcements by Elon often don't proceed at quite the pace that the market expects. FSD, solar roof tiles, etc... placing some stinkbids in the overnight for $VZ $T. https://t.co/Uyt8txNAb9

@BlueDuckCap Oct 8 3 clicks

BDC on X

This seems really positive for $stln as it validates their value prop to payers. https://t.co/RG5Js9xVFm

@DeepSailCapital Oct 8

Deep Sail Capital on X

AI trade calls $CRDO $LITE $AMD etc have been an easy trade lately, just buy them everytime it’s down +5% and sell in a day or too. Rinse and repeat.

@DeepSailCapital Oct 8

Deep Sail Capital on X

$ARQQ down 20% today on preliminary results. Still worth $300m or like 450x revenue. https://t.co/65vF1lGHP7

@StableBread Oct 8

Fajasy on X

Nuclear should bring in $3.7B of the $3.8B of revenue BWX Technologies $BWXT expects in 2026. $BWXT builds nuclear reactors and their heavy components, manufactures nuclear fuel, then services reactors once they’re running. It reports two segments: → Government Operations (73% of 2025 segment revenue, $2,350.1M): Reactors and fuel for the Navy’s submarines and aircraft carriers, uranium processing for the government, microreactor programs, and stakes in the joint ventures running government nuclear sites (booked as equity income, not revenue). → Commercial Operations (27%, $853.1M): Steam generators (heat exchangers turning reactor heat into steam), reactor pressure vessels, fuel, and field services for power utilities, mostly in Ontario. Also Kinectrics (a Toronto-based nuclear engineering and testing firm acquired in 2025) and a medical isotope unit $BWXT is selling. Naval propulsion is the core, at “a little bit less than 1/2” of revenue, CEO Rex Geveden said at $BWXT’s Investor Day on September 29, 2026. Special materials (the government uranium business) makes up 15-20%, and commercial power ~30%. The U.S. government accounted for 68% of 2025 revenue, directly or through prime contractors, down from 76% in 2024 as the commercial side grew. Four large utilities accounted for another 17%, per the FY2025 10-K. What keeps the Navy from switching suppliers is licensing. Only two plants in the U.S. hold Nuclear Regulatory Commission (NRC) licenses to produce fuel from high-enriched uranium (HEU, enriched to 20% or more, which is what naval reactors run on). Both belong to $BWXT (Nuclear Fuel Services in Erwin, Tennessee, and its Lynchburg plant), and the 10-K calls Nuclear Fuel Services “the sole provider of nuclear fuel for the U.S. Navy.”

@stockgutter Oct 8 4 clicks

SG on X

starting buy-writes in a bunch of beaten-down former "compounders" $POOL $AN compounder bros, what else should I be looking at in this regard? https://t.co/99vZNMmNIx

@stockgutter Oct 8

SG on X

Can we officially crown $ARQQ as the shittiest quantum stock of the bunch? Guided today to a whopping $1m revenue for 2026. I'm short via naked calls.

@blondesnmoney Oct 8

Cluseau Investments on X

$TLT to the entire AI complex today https://t.co/5Dt0Kg4Y3T

TSOH Weekly Roundup (10/09/2026)

Paramount Skydance’s debt-heavy Warner Bros. Discovery acquisition, streaming bundle pricing and alcohol-industry diversification anchor…

WBD $78B

TSOH Investment Research Oct 9

Blackstone Secured Lending: A Solid Balance Sheet But About To Cut Its Dividend - HOLD

Blackstone Secured Lending Fund faces a likely dividend cut after its first shortfall in 28 quarters, despite 1.8% non-accruals, $2.8…

BXSL $6.6B

Rubicon Associates Oct 9

Consumer agents: an ethics race, a prisoner’s dilemma, and the obvious OTA short

Consumer agents create an ethics race among AI labs and a prisoner’s dilemma for retailers, with online travel agencies framed as an…

EXPE $31BBKNG $118B

Yet Another Value Blog Oct 9 2 clicks

Hyster Yale (HY) Multibagger potential as confluence of negatives subside. Attractive after markets part services model

Hyster-Yale trades at 0.16 times sales as lift-truck bookings rebound and restructuring targets $85 million to $100 million in annual…

HY $582M

Calvin Blissett Oct 9 1 click

AppLovin: Why I'm Upgrading To Buy Following The Recent Pullback

AppLovin's Ads Manager targets middle-market e-commerce advertisers as Q3 guidance calls for 47% sales growth, while legal and compute-cost…

APP $93B

Jack Elias Oct 9 3 clicks

Research & Analysis: Legence Corp. (NASDAQ: LGN)

Legence trades at 10.4x EV/aEBITDA with a $5.7 billion backlog, as AI data center installations drive growth and expand its maintenance…

LGN $5.8B

Monte Independent Investment Research Oct 9

GoDaddy: The AI Transition Is Messy, But I'm Still Buying

GoDaddy’s Airo bookings run-rate rose from $10 million to $50 million in one quarter, but legacy Applications & Commerce declines still…

GDDY $13B

Fernanda Galvez Jalil Oct 9 2 clicks

Cava Group: Buying The (Feta) Dip? (Ticker: CAVA)

Cava’s $3 million AUVs, 25.1% restaurant margins and sector-leading same-store sales support its expansion case as awareness rose from 40%…

CAVA $6.1B

Emerging Moats Research Oct 9 5 clicks

Boyz in the Hood

Robinhood’s AI agents, 24/7 equity trading and 10:1 crypto perpetual futures encourage higher retail trading velocity, leverage and…

HOOD $98B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 8

Namib Minerals: Research Note

Namib Minerals posted H1 adjusted EBITDA of $19.0 million, up 76%, as higher gold prices offset lower production.

NAMM $62M

Atrium Research - Equity Research Oct 8

BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $314M

Value Investors Club Jul 12

Deckers: A 9% Earnings Yield With Q2 Approaching

Deckers trades at 11x forward earnings with $1.6 billion cash, no debt and aggressive buybacks, as HOKA growth and UGG profitability…

DECK $11B

TQP Research Oct 9

The Uranium Cycle Is Turning Up: In Conversation with YCA & Cameco

Yellow Cake and Cameco say U.S. utilities have contracted only 40% of 2030 uranium needs, setting up a new contracting cycle as…

CCJ $39B

Aurelion Research Oct 8 1 click

This Week in Special Situations: Constellation Brands, GEO Group, Under Armour, CITIC Resources

Special-situations survey profiles 26 activist, capital-return, M&A and strategic-alternative catalysts, led by buybacks at Under Armour,…

STZ $20BGEO $4.1B

Latticework by MOI Global Oct 8 2 clicks

The Story Millrose Told Wall Street About Lennar Purchases Doesn’t Match The Evidence

Millrose told Goldman its Lennar purchases had rent-to-own tenants lined up, but most analyzed homes were advertised for rent and showed…

LEN $18BMRP $3.8B

Hunterbrook Oct 8 4 clicks

Nike Taught Me A Dividend Lesson And A China Lesson (Rating Downgrade)

Nike's 4.8% dividend yield masks payout ratios above 100% of forward EPS and inadequate free cash flow coverage, while China sales declines…

NKE $51B

Sensor Unlimited Oct 8

Golar LNG q2’26 Operational Update

Golar LNG ordered a $2.45 billion fourth FLNG vessel, targeting 3.5MTPA of capacity and $400 million in annual EBITDA under a 20-year…

GLNG $4.9B

Monte Independent Investment Research Oct 8

Ex-Goldman MD: "Credit Markets Move in Step Functions"

Geoffrey Williams explains CMBS underwriting, post-GFC securitized-credit risk transfer and why credit markets reprice in step functions.

GS $257B

Odds on Open Oct 8 2 clicks

Top Rebound Stocks for Oct’26

Intuitive Surgical, down 32% from its January 2025 peak, faces slower US procedure growth and new robotic-surgery rivals despite $10.1…

ISRG $147B

Rebound Capital Oct 8 1 click

Credo: The Market Is Wrong About Optics, And That's Creating A Buying Opportunity

Credo expects optical revenue to reach $600 million in FY27 after Q1 revenue grew 114.7% year over year, expanding from AEC cables into AI…

CRDO $40B

Analysis Fundamental Oct 8 4 clicks

Saturday, October 10, 2026

SG on X

BDC on X

Deep Sail Capital on X

Deep Sail Capital on X

Fajasy on X

SG on X

SG on X

Cluseau Investments on X

Investor Letters

Publications we follow

Newsletters 92

YouTube 4

Blogs 12

Seeking Alpha 45 of 216

X accounts we follow

Investor letters we follow

Sectors